Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$247K Sell
1,100
-17,900
-94% -$4.46M ﹤0.01% 3911
2025
Q4
$4.58M Hold
19,000
﹤0.01% 2076
2025
Q3
$5.2M Hold
19,000
﹤0.01% 1941
2025
Q2
$4.9M Sell
19,000
-35,000
-65% -$8.35M ﹤0.01% 1911
2025
Q1
$12.1M Buy
54,000
+29,000
+116% +$6.77M 0.01% 1255
2024
Q4
$5.72M Sell
25,000
-67,500
-73% -$16.3M ﹤0.01% 1825
2024
Q3
$22.6M Buy
+92,500
New +$20.7M 0.01% 880
2021
Q1
Sell
-7,600
Closed -$1.61M 7194
2020
Q4
$1.61M Sell
7,600
-1,700
-18% -$339K ﹤0.01% 3065
2020
Q3
$1.59M Sell
9,300
-19,400
-68% -$3.58M ﹤0.01% 2864
2020
Q2
$5.51M Sell
28,700
-15,800
-36% -$2.59M ﹤0.01% 1782
2020
Q1
$6.55M Buy
44,500
+1,800
+4% +$287K 0.01% 1461
2019
Q4
$6.62M Sell
42,700
-1,200
-3% -$173K ﹤0.01% 1799
2019
Q3
$5.93M Sell
43,900
-28,100
-39% -$3.68M ﹤0.01% 1790
2019
Q2
$8.79M Sell
72,000
-800
-1% -$88.6K 0.01% 1491
2019
Q1
$7.57M Buy
72,800
+34,700
+91% +$3.58M 0.01% 1458
2018
Q4
$4.34M Buy
38,100
+30,800
+422% +$3.3M ﹤0.01% 1938
2018
Q3
$842K Buy
+7,300
New +$800K ﹤0.01% 3690

Other funds holding RMD

Citigroup's RMD Position: Q1 2026 in Review

Citigroup increased its ResMed (RMD) stake by 54% in Q1 2026, buying an estimated $34M and bringing the position to 390,082 shares worth $87.6M. The position accounts for 0.04% of the portfolio, ranked #446.

Citigroup first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Citigroup held 390,082 shares of ResMed worth $87.6M as of Q1 2026.
  • Citigroup bought 136,267 ResMed shares in Q1 2026, an estimated $34M.
  • ResMed made up 0.04% of Citigroup's portfolio in Q1 2026, its #446 holding.
  • Citigroup first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.